Merck Halts Trial Evaluating Combo Therapy for Metastatic Castration-Resistant Prostate Cancer
Following a planned interim analysis, the decision to halt the trial was made after a review of data by an independent Data Monitoring Committee.
Following a planned interim analysis, the decision to halt the trial was made after a review of data by an independent Data Monitoring Committee.
Racial disparity in the use of emerging diagnostic technologies may widen gaps in cancer treatment and outcomes, according to investigators.
Men of African ancestry had the highest risk of developing metastatic prostate cancer when compared with men of other ancestries.
The perioperative period is receiving increased attention as a platform to inhibit cancer progression, according to investigators.
A recent study examined the effect of neighborhood and individual socioeconomic deprivation on overall and cancer-specific survival among patients with prostate, breast, lung, and colorectal cancer.
Most prostate cancer deaths occur among men initially diagnosed with low-grade disease, according to investigators.
An update to active surveillance recommendations has some physicians concerned.
Recent studies showed associations between quality of life scores and survival in lung and prostate cancer as well as renal cell carcinoma.
The incidence of prostate cancer was significantly higher in MSH2 and MSH6 carriers than in noncarriers.
Respondents said some essential cancer drugs had substantial out-of-pocket costs, and some posed a high risk of catastrophic expenditure.